Skip to content

Efficacy of multi-modal intensive rehabilitation program after lung transplantation

Multi-modal intensive rehabilitation program after lung transplantation: a single-center randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063538
Enrollment
Unknown
Registered
2022-09-10
Start date
2022-09-30
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung transplantation

Interventions

Multi-modal intensive rehabilitation group:Multi-modal intensive rehabilitation program

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Lung transplant recipients for unilateral or bilateral lung transplantation; 2. Age criteria (13 to 80 years old);

Exclusion criteria

Exclusion criteria: 1. There are serious underlying diseases of the heart, brain, liver, kidney, or other important organs; 2. Mental and cognitive diseases cannot cooperate with rehabilitation; 3. Bone and joint injuries or fractures cannot cooperate with rehabilitation; 4. Severe illness as assessed by the clinician cannot tolerate rehabilitation; 5. The informed consent of the patient or family member cannot be obtained; 6. Surgical complications in the perioperative period; 7. Postoperative complications from non-surgical causes; 8. Those unable to follow the doctor's orders to complete the rehabilitation program.

Design outcomes

Primary

MeasureTime frame
The six minute walking distance;

Secondary

MeasureTime frame
Health related quality of life measured by SF-36;body composition analysis;grip strength;maximal quadriceps isometric strength;limb dimension (10cm above and below the patella of the quadriceps);MRC scale of muscle strength;Bathel index;The Physical Function in ICU Test-Scored (PFIT-S);Anxiety and Depression Self-Rating Scale;maximum inspiratory pressure (MIP);pulmonary function assessment;

Countries

China

Contacts

Public ContactWenhui Chen
wenhuichen1004@sina.com+86 10 84153885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026